Precision Medicine

Researchers Awarded $1.5 Million to Target Lung Cancer Cure
Research & Development Researchers Awarded $1.5 Million to Target Lung Cancer Cure

The persistent evolution of drug-resistant tumors has long remained the primary barrier to achieving a definitive cure for lung cancer patients who initially respond well to therapy. While modern medicine successfully transformed many terminal diagnoses into manageable chronic conditions, certain

Long COVID Immunoproteomics – Review
Tech & Innovation Long COVID Immunoproteomics – Review

The intricate dance between the human immune system and the ghost of a viral past is finally becoming visible through the lens of high-resolution immunoproteomics, a field that is effectively ending the era of diagnostic ambiguity for millions. This technological evolution represents a fundamental

AI and Registry Data Identify High-Risk Melanoma Patients
Tech & Innovation AI and Registry Data Identify High-Risk Melanoma Patients

The silent progression of melanoma often remains undetected until it reaches a critical stage, yet the digital fingerprints of this disease may already exist within the vast archives of national healthcare databases. A transformative study led by researchers at the University of Gothenburg and

Fatty Liver Disease Linked to Severe Foodborne Infections
Research & Development Fatty Liver Disease Linked to Severe Foodborne Infections

A routine dinner featuring raw oysters or a medium-rare burger might seem like a standard indulgence for most, yet for a growing segment of the global population, these meals represent a dangerous biological gamble. While a healthy individual might experience a brief bout of gastrointestinal

Mitochondrial Hub Controls Dendritic Cell Immune Readiness
Research & Development Mitochondrial Hub Controls Dendritic Cell Immune Readiness

Within the microscopic theater of the human body, a relentless surveillance network operates with such precision that most pathogens are neutralized long before symptoms ever appear. At the heart of this defensive perimeter are dendritic cells, the primary "sentinels" that bridge the gap between

How Will VALANX’s New Board Advance Cancer Drug Development?
Research & Development How Will VALANX’s New Board Advance Cancer Drug Development?

The precision required to dismantle a tumor without devastating the surrounding healthy tissue remains one of the most elusive targets in modern oncology. While the pharmaceutical industry has long sought to perfect antibody-drug conjugates (ADCs), the technical reality often falls short of the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later